Dexniguldipine Hydrochloride, a Protein-kinase-C-specific Inhibitor, Affects the Cell Cycle, Differentiation, P-glycoprotein Levels, and Nuclear Protein Phosphorylation in Friend Erythroleukemia Cells

Overview

Journal J Cancer Res Clin Oncol

Specialty Oncology

Date 1996 Jan 1

PMID 8698746

Citations 2

Authors

K K Patterson

B S Beckman

D M Klotz

C M Mallia

J R Jeter Jr

Affiliations

Soon will be listed here.

Abstract

Dexniguldipine hydrochloride (DNIG) is a potent antineoplastic agent with well-documented anti-(protein kinase C) activity and an ability to reverse multidrug resistance. Given the importance of protein kinase C (PKC) activity in proliferation and differentiation, we examined the effect of DNIG on several parameters of Friend erythroleukemia cell (FELC) activity. Particular attention was paid to proliferation, hexamethylene-bisacetamide-(HMBA)-induced differentiation, nuclear localization of protein kinase C, and nuclear protein phosphorylation. P-glycoprotein expression was also followed as an indicator of changes in multidrug resistance. At 2.5 microM, DNIG caused a significant decrease in the rate of FELC proliferation, while maintaining a cellular viability of greater than 80%, whether exposure to the drug was continuous over 96 h or took the form of a 6-h pulse/chase. DNA synthesis was decreased in cells exposed to DNIG for 20 h. Flow cytometry showed a marked increase in the percentage of cells in S phase of the cell cycle. Phosphorylation studies revealed decreased phosphorylation of two nuclear proteins (80 kDa and 47 kDa) following a 4-h exposure to the drug. HMBA-induced differentiation was significantly inhibited with continuous exposure to DNIG, and this effect appears to be a pre-commitment one, as 6-h pulse/chase exposures also resulted in inhibition of differentiation. Cells induced to differentiate with HMBA also demonstrated a decrease in the quantity of the 80-kDa phosphoprotein. Western blotting revealed that, even in the face of decreased phosphorylation, exposure to this PKC inhibitor resulted in an increase in the amount of nuclear PKC alpha. Finally, levels of P-glycoprotein were decreased in the presence of this drug. Our work identifies several effects of the PKC inhibitor DNIG on FELC and suggests several roles for PKC in regulating FELC proliferation and differentiation. Additionally, these results suggest that this PKC inhibitor may increase the effect of other chemotherapeutic drugs, particularly S-phase-specific ones, by increasing the length of S phase and decreasing multidrug resistance. The possibility of combination therapy with DNIG and other antineoplastic agents should be investigated further in light of these findings.

Citing Articles

Protein kinases and multidrug resistance.

Rumsby M, Drew L, Warr J Cytotechnology. 2008; 27(1-3):203-24.

PMID: 19002793 PMC: 3449563. DOI: 10.1023/A:1008073006495.

Streptomyces serine protease (DHP-A) as a new biocatalyst capable of forming chiral intermediates of 1,4-dihydropyridine calcium antagonists.

Arisawa A, Matsufuji M, Nakashima T, Dobashi K, Isshiki K, Yoshioka T Appl Environ Microbiol. 2002; 68(6):2716-25.

PMID: 12039725 PMC: 123970. DOI: 10.1128/AEM.68.6.2716-2725.2002.

References

Reymann A, Looft G, Woermann C, Dietel M, Erttmann R . Reversal of multidrug resistance in Friend leukemia cells by dexniguldipine-HCl. Cancer Chemother Pharmacol. 1993; 32(1):25-30. DOI: 10.1007/BF00685872. View

Spriggs L, Hill S, Jeter Jr J . Proliferation is required for induction of terminal differentiation of Friend erythroleukemia cells. Biochem Cell Biol. 1992; 70(7):555-64. DOI: 10.1139/o92-086. View

Krishan A, Sauerteig A, Stein J . Comparison of three commercially available antibodies for flow cytometric monitoring of P-glycoprotein expression in tumor cells. Cytometry. 1991; 12(8):731-42. DOI: 10.1002/cyto.990120807. View

Posada J, Vichi P, Tritton T . Protein kinase C in adriamycin action and resistance in mouse sarcoma 180 cells. Cancer Res. 1989; 49(23):6634-9. View

Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

Hocevar B, Fields A . Selective translocation of beta II-protein kinase C to the nucleus of human promyelocytic (HL60) leukemia cells. J Biol Chem. 1991; 266(1):28-33. View

Beckman B . Nuclear protein kinase C activity is decreased in Friend erythroleukemia cells induced to differentiate. Exp Hematol. 1992; 20(3):324-7. View

Neumann J, Housman D, Ingram V . Nuclear protein synthesis and phosphorylation in Friend erythroleukemia cells stimulated with DMSO. Exp Cell Res. 1978; 111(2):277-84. DOI: 10.1016/0014-4827(78)90171-4. View

Aftab D, Yang J, Hait W . Functional role of phosphorylation of the multidrug transporter (P-glycoprotein) by protein kinase C in multidrug-resistant MCF-7 cells. Oncol Res. 1994; 6(2):59-70. View

10.

Spruill W, Hurwitz D, Lucchesi J, Steiner A . Association of cyclic GMP with gene expression of polytene chromosomes of Drosophila melanogaster. Proc Natl Acad Sci U S A. 1978; 75(3):1480-4. PMC: 411496. DOI: 10.1073/pnas.75.3.1480. View

11.

Kartner N, Riordan J, Ling V . Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science. 1983; 221(4617):1285-8. DOI: 10.1126/science.6137059. View

12.

Mallia C, Jeter Jr J, Fields A, Wilson R, Beckman B . Protein kinase C beta from Friend erythroleukemia cells is associated with chromatin and DNA. Mol Cell Biochem. 1995; 151(2):107-11. DOI: 10.1007/BF01322332. View

13.

Krishan A . Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J Cell Biol. 1975; 66(1):188-93. PMC: 2109516. DOI: 10.1083/jcb.66.1.188. View

14.

Kiyokawa H, Richon V, Venta-Perez G, Rifkind R, Marks P . Hexamethylenebisacetamide-induced erythroleukemia cell differentiation involves modulation of events required for cell cycle progression through G1. Proc Natl Acad Sci U S A. 1993; 90(14):6746-50. PMC: 47009. DOI: 10.1073/pnas.90.14.6746. View

15.

Zhou W, Takuwa N, Kumada M, Takuwa Y . Protein kinase C-mediated bidirectional regulation of DNA synthesis, RB protein phosphorylation, and cyclin-dependent kinases in human vascular endothelial cells. J Biol Chem. 1993; 268(31):23041-8. View

16.

Roninson I, Chin J, Choi K, Gros P, Housman D, Fojo A . Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proc Natl Acad Sci U S A. 1986; 83(12):4538-42. PMC: 323769. DOI: 10.1073/pnas.83.12.4538. View

17.

Sasaguri T, Kosaka C, Hirata M, Masuda J, Shimokado K, Fujishima M . Protein kinase C-mediated inhibition of vascular smooth muscle cell proliferation: the isoforms that may mediate G1/S inhibition. Exp Cell Res. 1993; 208(1):311-20. DOI: 10.1006/excr.1993.1251. View

18.

Capitani S, Mazzoni M, Bertagnolo V, Previati M, DAddona A, Ricci D . Nuclear inositol lipids in Friend erythroleukemia cells. Changes related to differentiation induced by hexamethylenebisacetamide. Cell Biol Int Rep. 1990; 14(9):783-95. DOI: 10.1016/0309-1651(90)90005-j. View

19.

Fine R, Patel J, Chabner B . Phorbol esters induce multidrug resistance in human breast cancer cells. Proc Natl Acad Sci U S A. 1988; 85(2):582-6. PMC: 279595. DOI: 10.1073/pnas.85.2.582. View

20.

Ogawa M, PARMLEY R, Bank H, SPICER S . Human marrow erythropoiesis in culture. I. Characterization of methylcellulose colony assay. Blood. 1976; 48(3):407-17. View